Claritev Corporation (CTEV)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 938 | 1,118 | 1,080 | 962 | 931 | 965 | 995 | 1,015 |
| Operating profit | $m | 45 | 49 | ||||||
| Net profit | $m | -521 | 102 | -573 | -92 | -1,646 | -284 | -283 | -248 |
| EPS reported | $ | -17.30 | -17.01 | ||||||
| Operating cashflow per share | $ | 7.14 | 7.84 | ||||||
| Capex per share | $ | 7.89 | 8.90 | ||||||
| FCF per share | $ | -0.75 | -1.06 | ||||||
| Free cash flow | $m | -12 | -18 | ||||||
| Net debt | $m | 4,599 | 4,588 | ||||||
| Book value equity | $m | -174 | -295 | ||||||
| Book value per share | $ | -10.58 | -17.36 | ||||||
| Number of shares | m | 16.43 | 16.96 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -4.04 | -2.39 | ||||||
| P/S LTM | x | 0.73 | 0.71 | ||||||
| P/FCF LTM | x | -57.23 | -39.20 | ||||||
| EV/EBITDA LTM | x | 11.19 | 9.00 | ||||||
| EV/Sales LTM | x | 5.51 | 5.29 | ||||||
| Earnings Yield LTM | % | -40.46% | -43.42% | ||||||
| FCF Yield | % | -1.75% | -2.55% | ||||||
| Quality | |||||||||
| ROE | % | +163.47% | +139.56% | ||||||
| ROIC | % | +0.74% | +0.94% | ||||||
| Operating margin | % | +4.67% | +4.91% | ||||||
| Gross margin | % | +27.61% | +44.27% | ||||||
| FCF/Sales | % | -1.27% | -1.80% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +3.74% | +6.88% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.00 | -0.00 | ||||||
| Net Debt/EBITDA | x | 9.71 | 7.80 | ||||||
| EBIT/Net interest | x | 0.11 | 0.12 | ||||||
| Net debt/market cap | % | +6.57% | +7.05% | ||||||
| Net debt/Equity | x | -26.45 | -15.58 | ||||||
| Gross debt/equity | x | -26.64 | -15.69 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free